首页> PloS one> Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study).

Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study).

导出 OA

翻译打印收藏纠错

第一作者： Wolfgang,Hilbe

第一单位： Medical University Innsbruck, Department of Internal Medicine V (Haematology and Oncology), Innsbruck, Austria.

作者： Wolfgang,Hilbe ^[1] ; Georg,Pall ^[1] ; Florian,Kocher ^[2] ; Andreas,Pircher ^[1] ; August,Zabernigg ^[3] ; Thomas,Schmid ^[4] ; Michael,Schumacher ^[5] ; Herbert,Jamnig ^[6] ; Michael,Fiegl ^[1] ; Anne,Gächter ^[1] ; Martin,Freund ^[7] ; Dorota,Kendler ^[8] ; Claudia,Manzl ^[9] ; Bettina,Zelger ^[9] ; Helmut,Popper ^[10] ; Ewald,Wöll ^[11]

作者单位： Medical University Innsbruck, Department of Internal Medicine V (Haematology and Oncology), Innsbruck, Austria. ^[1] Medical University Innsbruck, Department of Internal Medicine V (Haematology and Oncology), Innsbruck, Austria; Tyrolean Cancer Research Institute, Innsbruck, Austria. ^[2] Department of Internal Medicine, County Hospital Kufstein, Kufstein, Austria. ^[3] Department of Surgery, Medical University Innsbruck, Innsbruck, Austria. ^[4] Department of Pneumology, General Hospital, Elisabethinen Linz, Linz, Austria. ^[5] Department of Pneumology, County Hospital Natters, Natters, Austria. ^[6] Department of Radiology, Medical University Innsbruck, Innsbruck, Austria. ^[7] Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria. ^[8] Department of Pathology, Medical University Innsbruck, Innsbruck, Austria. ^[9] Department of Pathology, Medical University Innsbruck, Innsbruck, Austria; Department of Pathology, Medical University Graz, Graz, Austria. ^[10] Department of Internal Medicine, Saint Vincent Hospital Zams, Zams, Austria. ^[11]